HPLC assay of phospholipase A2 activity using low-temperature derivatization of fatty acids

Analytical Letters

Volumn 42, Issue 10, 2009, Pages 1341-1351

  Atanasov, Vasil ^a   Petrova, Svetla ^a   Mitewa, Mariana ^a  

^a UNIVERSITY OF SOFIA   (Bulgaria)

Author keywords

Derivatization; Fatty acids; p bromophenacyl bromide; RP HPLC; Snake venom phospholipase A2

Indexed keywords

GLYCINE MAX;

EID: 70349793094     PISSN: 00032719     EISSN: 1532236X     Source Type: Journal    
DOI: 10.1080/00032710902954425     Document Type: Article

References (24)

1. Atanasov, V., V. Bardarov, B. Aleksiev, and M. Mitewa. 2005. Vipoxin specificity studied by gas chromatographic determination of the enzyme reaction products: Influence of Ca, Mg, and Sr. J. Venom. Anim. Toxins Trop. Dis. 11: 350-359.
2. Atanasov, V. N., D. Danchev, M. Mitewa, and S. Petrova. 2009. Hemolytic and anticoagulant study of the neurotoxin vipoxin and its components-Basic phos-pholipase A2 and an acidic inhibitor. Biochemistry (Moscow) 74: 339-345.
3. Dole, V. P., and H. Meinertz. 1960. Microdetermination of long-chain fatty acids in plasma and tissues. J. Biol. Chem. 235: 2595-2599.
4. Durst, H. D., M. Milano, E. J. Kikta Jr., S. A. Connelly, and E. Grushka. 1975. Phenacyl esters of fatty acids via crown ether catalysts for enhanced ultraviolet detection in liquid chromatography. Anal. Chem. 47: 1797-1801.
5. Elsbach, P., and J. Weiss. 1991. Utilization of labeled Escherichia coli as phospho-lipase substrate. In Methods in Enzymology, ed. E. A. Dennis. San Diego: Academic Press.
6. Hoffmann, G. E., and W. G. Guder. 1989. Serum phospholipase: Regulatory and patophysiological aspects. Klin. Wochenschr. 67: 144-148.
7. Kaiser, E., P. Chiba, and K. Zaky. 1990. Phospholipases in biology and medicine. Clin. Biochem. 23: 349-370.
8. Kline, W. F., D. P. Enagonio, D. J. Reeder, and W. E. May. 1982. Liquid chromatographic determination of valproic acid in human serum. J. Liq. Chromatogr. 5: 1697-1709.
9. Kudo, I., and M. Murakami. 2002. Phospholipase A2 enzymes. Prostag. Oth. Lipid M. 68-69: 3-58
10. Miller, A. A., E. Kurschel, R. Osieva, and C. G. Schmidt. 1987. Clinical pharmacology of sodium butyrate in patients with acute leukemia. Eur. J. Cancer Clin. Oncol. 23: 1283-1287.
11. Mobilio, D., and L. A. Marshall. 1989. Recent advances in the design and evaluation of inhibitors of PLA2. Ann. Rep. Med. Chem. 24: 157-166.
12. Mohamed Shakir, K. M. 1981. Phospholipase A2 activity of post-heparin plasma: A rapid and sensitive assay and partial characterization. Anal. Biochem. 114: 64-70.
13. Moody, J. P., and S. M. Allan. 1983. Measurement of valproic acid in serum as the 4-bromophenacyl ester by high performance liquid chromatography. Clin. Chim. Acta 127: 263-269.
14. Nikolova-Damyanova, B. 1997. Reversed phase HPLC: General principles and application to fatty acids and triacylglycerols. In Advances in Lipid Methodology Four, ed. W. W. Christie. Dundee, Scotland: Oily Press.
15. Nuhn, P., L. Heine, and R. Benecke. 1985. Gaschromatographische Aktivitaets-bestimmung von Phospholipase A2. Zentralbl. Pharm. 124: 77-81.
16. Pei, P. T., W. G. Kossa, S. Ramachandran, and R. S. Henly. 1976. High pressure reverse phase liquid chromatography of fatty acids p-bromophenacyl esters. Lipids 11: 814-816.
17. Pind, S., and A. Kuksis. 1988. Solubilization and assay of phospholipase A2 activity from rat jejunal brush-border membranes. Biochim. Biophys. Acta 938: 211-221.
18. Pungercar, J., and I. Krizaj. 2007. Understanding the molecular mechanism underlying the presynaptic toxicity of secreted phospholipases A2. Toxicon 50: 871-892.
19. Puttmann, M., H. Krug, E. von Ochsenstein, and R. Kattermann. 1993. Fast HPLC determination of serum free fatty acids in the picomole range. Clin. Chem. 39: 825-832.
20. Richieri, G. V., and A. M. Kleinfield.1995. Continuous measurement of phospholipase A2activity using the fluorescent probe ADIFAB. Anal. Biochem. 229: 256-263.
21. Rigoni, M., P. Caccin, S. Gschmeissner, G. Koster, A. D. Postle, O. Rosseto, G. Schiavo, and C. Montecucco. 2005. Equivalent effects of snake PLA2 neurotox-ins and lysophospholipid-fatty acid mixtures. Science 310: 1678-1680.
22. Schmitt, M., and M. Lehr. 2004. HPLC assay with UV spectrometric detection for the evaluation of inhibitors of cytosolic phospholipase A2. J. Pharm. Biomed. Anal. 35: 135-142.
23. Tojo, H., T. Ono, and M. Okamoto. 1993. Reverse-phase high performance liquid chromatographic assay of phospholipases: Application of spectrophotometric detection to rat phospholipase A2 isozymes. J. Lipid Res. 34: 837-844.
24. Wilton, D. C. 1990. A continuous fluorescence displacement assay for the measurement of phospholipase A2 and other lipases that release long-chain fatty acids. Biochem. J. 266: 435-439.